RHUMBLINE ADVISERS

Position in RDHL — RedHill Biopharma Ltd.

CIK 1115418 BOSTON, MA

Position in RDHL

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$11,622

+$7,811 QoQ

Shares Held

13,755

+168.9% QoQ

Ownership

0.226%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 14 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $455,921,156 across 48 Drug Manufacturers - Specialty & Generic names. RDHL ranks #44 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,437,213	$103,278,126
2	UTHR	UNITED THERAPEUTICS Corp	120,078	$65,061,862
3	NBIX	Neurocrine Biosciences Inc	312,832	$52,724,705
4	VTRS	Viatris Inc	2,872,464	$45,614,728
5	ELAN	Elanco Animal Health Inc	1,264,159	$31,110,952
6	HIMS	Hims & Hers Health, Inc.	633,778	$21,973,083
7	LNTH	Lantheus Holdings, Inc.	197,060	$21,861,836
8	ALKS	Alkermes plc.	387,999	$20,331,147

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,622	13,755	+168.9%	Shares	Sole	2026-08-12
2026-03-31	$3,811	5,116	+91.0%	Shares	Sole	2026-05-12
2025-12-31	$2,758	2,678	+51.5%	Shares	Sole	2026-02-13
2025-09-30	$3,836	1,768	0.0%	Shares	Sole	2025-11-06
2025-06-30	$3,429	1,768	+27.4%	Shares	Sole	2025-08-12
2025-03-31	$3,692	1,388	+15.9%	Shares	Sole	2025-05-29
2024-12-31	$7,439	1,198	+22.4%	Shares	Sole	2025-05-29
2024-09-30	$8,557	979	-94.8%	Shares	Sole	2024-11-12
2024-06-30	$7,021	18,927	-37.3%	Shares	Sole	2024-08-01
2024-03-31	$15,999	30,187	-13.4%	Shares	Sole	2024-05-09
2023-12-31	$50,876	34,847	+1056.2%	Shares	Sole	2024-02-08
2023-09-30	$1,537	3,014	0.0%	Shares	Sole	2023-11-09
2023-06-30	$3,616	3,014	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.